Normal mode-based approaches in receptor ensemble docking.

Explicitly accounting for target flexibility in docking still constitutes a difficult challenge due to the high dimensionality of the conformational space to be sampled. This especially applies to the high-throughput scenario, where the screening of hundreds of thousands compounds takes place. The use of multiple receptor conformations (MRCs) to perform ensemble docking in a sequential fashion is a simple but powerful approach that allows to incorporate binding site structural diversity in the docking process. Whenever enough experimental structures to build a diverse ensemble are not available, normal mode analysis provides an appealing and efficient approach to in silico generate MRCs by distortion along few low-frequency modes that represent collective mid- and large-scale displacements. In this way, the dimension of the conformational space to be sampled is heavily reduced. This methodology is especially suited to incorporate target flexibility at the backbone level. In this chapter, the main components of normal mode-based approaches in the context of ensemble docking are presented and explained, including the theoretical and practical considerations needed for the successful development and implementation of this methodology.

[1]  S. Kim,et al.  "Soft docking": matching of molecular surface cubes. , 1991, Journal of molecular biology.

[2]  M. Zacharias,et al.  Accounting for global protein deformability during protein-protein and protein-ligand docking. , 2005, Biochimica et biophysica acta.

[3]  X. Barril,et al.  Unveiling the full potential of flexible receptor docking using multiple crystallographic structures. , 2005, Journal of medicinal chemistry.

[4]  B. Shoichet,et al.  Soft docking and multiple receptor conformations in virtual screening. , 2004, Journal of medicinal chemistry.

[5]  S. Ozkan,et al.  A flexible docking scheme to explore the binding selectivity of PDZ domains , 2010, Protein science : a publication of the Protein Society.

[6]  D. Pérahia,et al.  Normal mode analysis as a prerequisite for drug design: Application to matrix metalloproteinases inhibitors , 2006, FEBS letters.

[7]  Olivier Sperandio,et al.  How to choose relevant multiple receptor conformations for virtual screening: a test case of Cdk2 and normal mode analysis , 2010, European Biophysics Journal.

[8]  I. Bahar,et al.  Coarse-grained normal mode analysis in structural biology. , 2005, Current opinion in structural biology.

[9]  S. Teague Implications of protein flexibility for drug discovery , 2003, Nature Reviews Drug Discovery.

[10]  Claudio N. Cavasotto and Narender Singh Docking and High Throughput Docking: Successes and the Challenge of Protein Flexibility , 2008 .

[11]  Claudio N. Cavasotto,et al.  Representing receptor flexibility in ligand docking through relevant normal modes. , 2005, Journal of the American Chemical Society.

[12]  A. Leach,et al.  Ligand docking to proteins with discrete side-chain flexibility. , 1994, Journal of molecular biology.

[13]  J. W. Humberston Classical mechanics , 1980, Nature.

[14]  Richard A. Lewis,et al.  Lessons in molecular recognition: the effects of ligand and protein flexibility on molecular docking accuracy. , 2004, Journal of medicinal chemistry.

[15]  Holger Gohlke,et al.  Target flexibility: an emerging consideration in drug discovery and design. , 2008, Journal of medicinal chemistry.

[16]  C. Humblet,et al.  Modeling G protein‐coupled receptors for structure‐based drug discovery using low‐frequency normal modes for refinement of homology models: Application to H3 antagonists , 2010, Proteins.

[17]  M. Zacharias,et al.  Protein-ligand docking accounting for receptor side chain and global flexibility in normal modes: evaluation on kinase inhibitor cross docking. , 2008, Journal of medicinal chemistry.

[18]  H. Wolfson,et al.  FiberDock: Flexible induced‐fit backbone refinement in molecular docking , 2010, Proteins.

[19]  Erin S. Bolstad,et al.  In pursuit of virtual lead optimization: The role of the receptor structure and ensembles in accurate docking , 2008, Proteins.

[20]  H. Scheraga,et al.  Monte Carlo-minimization approach to the multiple-minima problem in protein folding. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[21]  G. Phillips,et al.  Optimization and evaluation of a coarse-grained model of protein motion using x-ray crystal data. , 2006, Biophysical journal.

[22]  Claudio N. Cavasotto,et al.  Ligand docking and structure-based virtual screening in drug discovery. , 2007, Current topics in medicinal chemistry.

[23]  Claudio N. Cavasotto,et al.  Scalaradial, a Dialdehyde‐Containing Marine Metabolite That Causes an Unexpected Noncovalent PLA2 Inactivation , 2007, Chembiochem : a European journal of chemical biology.

[24]  W. L. Jorgensen The Many Roles of Computation in Drug Discovery , 2004, Science.

[25]  R. Glen,et al.  Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. , 1995, Journal of molecular biology.

[26]  Claudio N. Cavasotto,et al.  Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening. , 2008, Journal of medicinal chemistry.

[27]  Ivet Bahar,et al.  Computational Generation inhibitor-Bound Conformers of P38 Map Kinase and Comparison with Experiments , 2011, Pacific Symposium on Biocomputing.

[28]  M. Levitt,et al.  Protein normal-mode dynamics: trypsin inhibitor, crambin, ribonuclease and lysozyme. , 1985, Journal of molecular biology.

[29]  Claudio N. Cavasotto,et al.  Homology modeling in drug discovery: current trends and applications. , 2009, Drug discovery today.

[30]  Claudio N. Cavasotto,et al.  Ligand-Steered Modeling and Docking: A Benchmarking Study in Class A G-Protein-Coupled Receptors , 2010, J. Chem. Inf. Model..

[31]  Ivet Bahar,et al.  Anisotropic network model: systematic evaluation and a new web interface , 2006, Bioinform..

[32]  Pieter F. W. Stouten,et al.  Fast prediction and visualization of protein binding pockets with PASS , 2000, J. Comput. Aided Mol. Des..

[33]  Campbell McInnes,et al.  Virtual screening strategies in drug discovery. , 2007, Current opinion in chemical biology.

[34]  K. Hinsen Analysis of domain motions by approximate normal mode calculations , 1998, Proteins.

[35]  V. Pande,et al.  Can conformational change be described by only a few normal modes? , 2006, Biophysical journal.

[36]  Erik Lindahl,et al.  Refinement of docked protein–ligand and protein–DNA structures using low frequency normal mode amplitude optimization , 2005, Nucleic acids research.

[37]  Ruth Nussinov,et al.  An integrated suite of fast docking algorithms , 2010, Proteins.

[38]  Tirion,et al.  Large Amplitude Elastic Motions in Proteins from a Single-Parameter, Atomic Analysis. , 1996, Physical review letters.

[39]  Maria A Miteva,et al.  Structure-based virtual ligand screening: recent success stories. , 2009, Combinatorial chemistry & high throughput screening.

[40]  David Perahia,et al.  Activation of the ghrelin receptor is described by a privileged collective motion: a model for constitutive and agonist-induced activation of a sub-class A G-protein coupled receptor (GPCR). , 2010, Journal of molecular biology.

[41]  Peter A. Kollman,et al.  AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules , 1995 .

[42]  Claudio N. Cavasotto,et al.  Protein flexibility in ligand docking and virtual screening to protein kinases. , 2004, Journal of molecular biology.

[43]  Mark Gerstein,et al.  Normal mode analysis of macromolecular motions in a database framework: Developing mode concentration as a useful classifying statistic , 2002, Proteins.

[44]  Adrian A Canutescu,et al.  Cyclic coordinate descent: A robotics algorithm for protein loop closure , 2003, Protein science : a publication of the Protein Society.

[45]  F. J. Luque,et al.  Protein flexibility and ligand recognition: challenges for molecular modeling. , 2011, Current topics in medicinal chemistry.

[46]  Brian K. Shoichet,et al.  Virtual screening of chemical libraries , 2004, Nature.

[47]  Rommie E. Amaro,et al.  Emerging methods for ensemble-based virtual screening. , 2010, Current topics in medicinal chemistry.

[48]  Claudio N. Cavasotto,et al.  Conformational Sampling of Protein Flexibility in Generalized Coordinates: Application to Ligand Docking , 2005 .

[49]  C. Cavasotto,et al.  The binding mode of petrosaspongiolide M to the human group IIA phospholipase A(2): exploring the role of covalent and noncovalent interactions in the inhibition process. , 2009, Chemistry.

[50]  Ruben Abagyan,et al.  Consistent Improvement of Cross-Docking Results Using Binding Site Ensembles Generated with Elastic Network Normal Modes , 2009, J. Chem. Inf. Model..

[51]  X. Barril,et al.  Incorporating protein flexibility into docking and structure-based drug design , 2006, Expert opinion on drug discovery.

[52]  R. Jernigan,et al.  Anisotropy of fluctuation dynamics of proteins with an elastic network model. , 2001, Biophysical journal.

[53]  A. Atilgan,et al.  Direct evaluation of thermal fluctuations in proteins using a single-parameter harmonic potential. , 1997, Folding & design.

[54]  H. Gohlke,et al.  Large‐scale comparison of protein essential dynamics from molecular dynamics simulations and coarse‐grained normal mode analyses , 2010, Proteins.

[55]  A. Anderson The process of structure-based drug design. , 2003, Chemistry & biology.

[56]  I. Bahar,et al.  Normal mode analysis of biomolecular structures: functional mechanisms of membrane proteins. , 2010, Chemical reviews.

[57]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[58]  Ivet Bahar,et al.  Elastic network models for understanding biomolecular machinery: from enzymes to supramolecular assemblies , 2005, Physical biology.